<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04394611</url>
  </required_header>
  <id_info>
    <org_study_id>CengizGWCH6</org_study_id>
    <nct_id>NCT04394611</nct_id>
  </id_info>
  <brief_title>Metals and in Fetal Growth Restriction</brief_title>
  <acronym>FGR&amp;metals</acronym>
  <official_title>Analysis of Some Heavy Metals and Some Vitamins Levels in Maternal Samples, Fetal Samples and Breast Milk for Fetal Growth Restriction.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cengiz Gokcek Women's and Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cengiz Gokcek Women's and Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction: Intrauterine fetal growth restriction (FGR) is a condition in which the fetus
      does not realize its growth potential in the uterus. Heavy metals important pollutants
      produced from anthropogenic activities, has been suggested to be embryotoxic and fetotoxic in
      a lot of studies. However, the causes of fetal growth restriction are little known and heavy
      metals merit further investigation. The investigators will be tested whether fetal growth
      restriction was associated with exposure to these metals/vitamins.

      Methods: This study was designed to determine maternal plasma/urine/hair, cord plasma,
      placenta and breast milk tin (Sn), manganese (Mn), Vanadium (V), Magnesium (Mg), cobalt (Co),
      nickel (Ni), arsenic (As), chromium (Cr), cadmium (Cd), lead (Pb), mercury (Hg), antimony
      (Sb), aluminium (Al), zinc (Zn), copper (Cu), selenium (Se), iron (Fe), vitamin D, vitamin A,
      vitamin B12 and folate concentrations in women with FGR (n=55) compared to those of volunteer
      healthy pregnant women (n=55). These heavy metals concentrations measured using inductively
      coupled plasma-mass spectrometry were compared.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This observational case-control study will be conducted at the Department of Obstetrics and
      Gynecology, Cengiz Gokcek Public Hospital, Gaziantep, Turkey, between May 2020 and February
      2021. The protocol was approved by the Ethics Committee for Clinical Research of Gaziantep
      University (reference no: 2020/131). The study strictly will be adhered to the principles of
      the Declaration of Helsinki. All subjects will be included in the study gave oral and written
      informed consent. FGR was defined as an estimated fetal weight (grams) less than the 10th
      percentile for gestational age. Hadlock I formula were used to calculating estimated fetal
      weight percentiles. Every woman in the study population will be undergone obstetric
      ultrasound/doppler examination and fetal-maternal assessment will be carried out. Then, this
      study will be determined maternal plasma/urine/hair, cord plasma, placenta and breast milk
      tin (Sn), manganese (Mn), Vanadium (V), Magnesium (Mg), cobalt (Co), nickel (Ni), arsenic
      (As), chromium (Cr), cadmium (Cd), lead (Pb), mercury (Hg), antimony (Sb), aluminium (Al),
      zinc (Zn), copper (Cu), selenium (Se), iron (Fe), vitamin D, vitamin A, vitamin B12 and
      folate concentrations in women with FGR (n=55) compared to those of volunteer healthy
      pregnant women (n=55).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 30, 2020</start_date>
  <completion_date type="Anticipated">March 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>measurements of metals (µg/L) and vitamins concentrations for both groups</measure>
    <time_frame>10 day</time_frame>
    <description>The primary outcome in these analyses will measure tin (Sn), manganese (Mn), Vanadium (V), Magnesium (Mg), cobalt (Co), nickel (Ni), arsenic (As), chromium (Cr), cadmium (Cd), lead (Pb), mercury (Hg), antimony (Sb), aluminium (Al), zinc (Zn), copper (Cu), selenium (Se), and iron (Fe) concentrations in FGR group and control group. Moreover, the other primary outcome in these analyses will also measure vitamin D, vitamin A, vitamin B12 and folate concentrations in FGR group and control group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>compare the neonatal outcomes for both groups</measure>
    <time_frame>1 day</time_frame>
    <description>The secondary outcome in these analyses will compare composite neonatal outcome (APGAR scores, weight, length, head circumference, abdominal circumference, placental weight and NICU admission) in FGR group and control group.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">55</enrollment>
  <condition>Fetal Growth Restriction</condition>
  <arm_group>
    <arm_group_label>Fetal Growth Restriction (FGR)</arm_group_label>
    <description>FGR will be defined as an estimated fetal weight (grams) less than the 10th percentile for gestational age. Hadlock I formula will be used to calculating estimated fetal weight percentiles</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>healthy pregnancies will be selected for the control group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Obstetric ultrasound- doppler examination</intervention_name>
    <description>Obstetric ultrasound- doppler examination and fetal- maternal assessment Tin (Sn), manganese (Mn), Vanadium (V), Magnesium (Mg), cobalt (Co), nickel (Ni), arsenic (As), chromium (Cr), cadmium (Cd), lead (Pb), mercury (Hg), antimony (Sb), aluminum (Al), zinc (Zn), copper (Cu), selenyum (Se), iron (Fe), vitamin D, vitamin A, vitamin B12 and folate concentrations measurements</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Fetal Growth Restriction (FGR)</arm_group_label>
    <other_name>metals measurements</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      maternal plasma/urine/hair, cord plasma, placenta and breast milk
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The investigators consecutively will be recruited 55 subjects with Fetal growth
        restriction, and 55 healthy pregnancies will be selected for the control group.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women complicated with fetal growth restriction

          -  healthy pregnancy

          -  singleton pregnancy

        Exclusion Criteria:

          1. pregnant women with any systemic condition (such as chronic hypertension, renal
             disease and )

          2. Women who have dyed their hair in the last 9 months

          3. history of using any medication

          4. Presence of gestational hypertension or gestational diabetes

          5. drug user

          6. patients who had fetal congenital abnormalities or genetic syndromes

          7. multiple-gestation pregnancies

          8. intrauterine fetal death
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnancy</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cengiz Gokcek Women's and Child's hospital</name>
      <address>
        <city>Gaziantep</city>
        <zip>27010</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali Ovayolu, MD</last_name>
      <phone>00905326404060</phone>
      <email>drovayolu@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Xiong YW, Zhu HL, Nan Y, Cao XL, Shi XT, Yi SJ, Feng YJ, Zhang C, Gao L, Chen YH, Xu DX, Wang H. Maternal cadmium exposure during late pregnancy causes fetal growth restriction via inhibiting placental progesterone synthesis. Ecotoxicol Environ Saf. 2020 Jan 15;187:109879. doi: 10.1016/j.ecoenv.2019.109879. Epub 2019 Oct 31.</citation>
    <PMID>31677567</PMID>
  </results_reference>
  <results_reference>
    <citation>Eroglu H, Turgal M, Senat A, Karakoc G, Neselioglu S, Yucel A. Maternal and fetal thiol/disulfide homeostasis in fetal growth restriction. J Matern Fetal Neonatal Med. 2019 Aug 5:1-8. doi: 10.1080/14767058.2019.1646239. [Epub ahead of print]</citation>
    <PMID>31327276</PMID>
  </results_reference>
  <results_reference>
    <citation>Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, Silver RM, Wynia K, Ganzevoort W. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2016 Sep;48(3):333-9. doi: 10.1002/uog.15884.</citation>
    <PMID>26909664</PMID>
  </results_reference>
  <results_reference>
    <citation>Jiang M, Li Y, Zhang B, Zhou A, Zheng T, Qian Z, Du X, Zhou Y, Pan X, Hu J, Wu C, Peng Y, Liu W, Zhang C, Xia W, Xu S. A nested case-control study of prenatal vanadium exposure and low birthweight. Hum Reprod. 2016 Sep;31(9):2135-41. doi: 10.1093/humrep/dew176. Epub 2016 Jul 4.</citation>
    <PMID>27381766</PMID>
  </results_reference>
  <results_reference>
    <citation>Sabra S, Malmqvist E, Saborit A, Gratacós E, Gomez Roig MD. Heavy metals exposure levels and their correlation with different clinical forms of fetal growth restriction. PLoS One. 2017 Oct 6;12(10):e0185645. doi: 10.1371/journal.pone.0185645. eCollection 2017.</citation>
    <PMID>28985223</PMID>
  </results_reference>
  <results_reference>
    <citation>Ovayolu A, Ovayolu G, Karaman E, Yuce T, Ozek MA, Turksoy VA. Amniotic fluid levels of selected trace elements and heavy metals in pregnancies complicated with neural tube defects. Congenit Anom (Kyoto). 2019 Nov 19. doi: 10.1111/cga.12363. [Epub ahead of print]</citation>
    <PMID>31743503</PMID>
  </results_reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 10, 2020</study_first_submitted>
  <study_first_submitted_qc>May 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2020</study_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cengiz Gokcek Women's and Children's Hospital</investigator_affiliation>
    <investigator_full_name>Ali Ovayolu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fetal Growth Retardation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 9, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/11/NCT04394611/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

